Cargando…
Dissecting the Binding Profile of PET Tracers to Corticobasal Degeneration Tau Fibrils
[Image: see text] Alzheimer’s disease and primary tauopathies are characterized by the presence of tau pathology in brain. Several tau positron emission tomography (PET) tracers have been developed and studied in Alzheimer’s disease (AD), but there is still a lack of 4R-tau specific tracers for non-...
Autores principales: | Zhou, Yang, Li, Junhao, Nordberg, Agneta, Ågren, Hans |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2021
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8447187/ https://www.ncbi.nlm.nih.gov/pubmed/34464084 http://dx.doi.org/10.1021/acschemneuro.1c00536 |
Ejemplares similares
-
Cryptic Sites in Tau Fibrils Explain the Preferential
Binding of the AV-1451 PET Tracer toward Alzheimer’s Tauopathy
por: Murugan, N. Arul, et al.
Publicado: (2021) -
Insight into
the Binding of First- and Second-Generation
PET Tracers to 4R and 3R/4R Tau Protofibrils
por: Li, Junhao, et al.
Publicado: (2023) -
Discriminative binding of tau PET tracers PI2620, MK6240 and RO948 in Alzheimer’s disease, corticobasal degeneration and progressive supranuclear palsy brains
por: Malarte, Mona-Lisa, et al.
Publicado: (2022) -
Cross-interaction of tau PET tracers with monoamine oxidase B: evidence from in silico modelling and in vivo imaging
por: Murugan, N. Arul, et al.
Publicado: (2019) -
Novel tau filament fold in corticobasal degeneration
por: Zhang, Wenjuan, et al.
Publicado: (2020)